Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.
Article Details
- CitationCopy to clipboard
Anassi E, Ndefo UA
Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.
P T. 2011 Apr;36(4):197-202.
- PubMed ID
- 21572775 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs